药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Betaprodine
Metreleptin
The metabolism of Baricitinib can be increased when combined with Metreleptin.
Betaprodine
Armodafinil
The metabolism of Baricitinib can be increased when combined with Armodafinil.
Betaprodine
Sipuleucel-T
The therapeutic efficacy of Sipuleucel-T can be decreased when used in combination with Baricitinib.
Betaprodine
Roflumilast
Roflumilast may increase the immunosuppressive activities of Baricitinib.
Betaprodine
Siponimod
The risk or severity of adverse effects can be increased when Baricitinib is combined with Siponimod.
Betaprodine
Ibrutinib
The risk or severity of adverse effects can be increased when Ibrutinib is combined with Baricitinib.
Betaprodine
Bleselumab
The risk or severity of adverse effects can be increased when Baricitinib is combined with Bleselumab.
Betaprodine
Rozanolixizumab
The risk or severity of adverse effects can be increased when Baricitinib is combined with Rozanolixizumab.
Betaprodine
Risankizumab
The risk or severity of adverse effects can be increased when Baricitinib is combined with Risankizumab.
Betaprodine
Monomethyl fumarate
The risk or severity of adverse effects can be increased when Baricitinib is combined with Monomethyl fumarate.
Betaprodine
Tetrandrine
The risk or severity of adverse effects can be increased when Baricitinib is combined with Tetrandrine.
Betaprodine
Fluclorolone
The risk or severity of adverse effects can be increased when Baricitinib is combined with Fluclorolone.
Betaprodine
Fluperolone
The risk or severity of adverse effects can be increased when Baricitinib is combined with Fluperolone.
Betaprodine
Begelomab
The risk or severity of adverse effects can be increased when Baricitinib is combined with Begelomab.
Betaprodine
Fluocortin
The risk or severity of adverse effects can be increased when Baricitinib is combined with Fluocortin.
Betaprodine
9-(N-methyl-L-isoleucine)-cyclosporin A
The risk or severity of adverse effects can be increased when Baricitinib is combined with 9-(N-methyl-L-isoleucine)-cyclosporin A.
Betaprodine
Hypericin
The risk or severity of adverse effects can be increased when Baricitinib is combined with Hypericin.
Betaprodine
Acteoside
The risk or severity of adverse effects can be increased when Baricitinib is combined with Acteoside.
Betaprodine
Deoxyspergualin
The risk or severity of adverse effects can be increased when Baricitinib is combined with Deoxyspergualin.
Betaprodine
Doxifluridine
The risk or severity of adverse effects can be increased when Baricitinib is combined with Doxifluridine.